These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective. Barriere SL Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670 [TBL] [Abstract][Full Text] [Related]
9. Aerosolized antibiotics for treating hospital-acquired and ventilator-associated pneumonia. Wood GC Expert Rev Anti Infect Ther; 2011 Nov; 9(11):993-1000. PubMed ID: 22029519 [TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria. Rattanaumpawan P; Lorsutthitham J; Ungprasert P; Angkasekwinai N; Thamlikitkul V J Antimicrob Chemother; 2010 Dec; 65(12):2645-9. PubMed ID: 20876621 [TBL] [Abstract][Full Text] [Related]
11. Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box. Craven DE; Hjalmarson KI Clin Infect Dis; 2010 Aug; 51 Suppl 1():S59-66. PubMed ID: 20597674 [TBL] [Abstract][Full Text] [Related]
12. Aerosolized antibiotics in the intensive care unit. Palmer LB Clin Chest Med; 2011 Sep; 32(3):559-74. PubMed ID: 21867823 [TBL] [Abstract][Full Text] [Related]
13. Inhaled colistin as adjunctive therapy to intravenous colistin for the treatment of microbiologically documented ventilator-associated pneumonia: a comparative cohort study. Korbila IP; Michalopoulos A; Rafailidis PI; Nikita D; Samonis G; Falagas ME Clin Microbiol Infect; 2010 Aug; 16(8):1230-6. PubMed ID: 19732088 [TBL] [Abstract][Full Text] [Related]
15. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Michalopoulos A; Kasiakou SK; Mastora Z; Rellos K; Kapaskelis AM; Falagas ME Crit Care; 2005 Feb; 9(1):R53-9. PubMed ID: 15693967 [TBL] [Abstract][Full Text] [Related]
16. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study. Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J; Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979 [TBL] [Abstract][Full Text] [Related]
17. High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Chung DR; Song JH; Kim SH; Thamlikitkul V; Huang SG; Wang H; So TM; Yasin RM; Hsueh PR; Carlos CC; Hsu LY; Buntaran L; Lalitha MK; Kim MJ; Choi JY; Kim SI; Ko KS; Kang CI; Peck KR; Am J Respir Crit Care Med; 2011 Dec; 184(12):1409-17. PubMed ID: 21920919 [TBL] [Abstract][Full Text] [Related]
18. Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents. Goldstein I; Chastre J; Rouby JJ Semin Respir Crit Care Med; 2006 Feb; 27(1):82-91. PubMed ID: 16508884 [TBL] [Abstract][Full Text] [Related]
19. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan. Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293 [TBL] [Abstract][Full Text] [Related]
20. Considerations in undertaking a clinical development program for hospital-acquired bacterial pneumonia and/or ventilator-associated bacterial pneumonia. Talbot GH Clin Infect Dis; 2010 Aug; 51 Suppl 1():S144-9. PubMed ID: 20597665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]